This work is licensed under the Creative Commons Attribution 4.0 International License.
Cordie A, AbdAllah M, Vergori A, Kharono B, Karkouri M, Esmat G. Human immunodeficiency virus (HIV) and coronavirus disease 2019; impact on vulnerable populations and harnessing lessons learnt from HIV programmes. New Microbes New Infect. 2021;41:100857. doi: 10.1016/j.nmni.2021.100857CordieAAbdAllahMVergoriAKharonoBKarkouriMEsmatGHuman immunodeficiency virus (HIV) and coronavirus disease 2019; impact on vulnerable populations and harnessing lessons learnt from HIV programmes20214110085710.1016/j.nmni.2021.100857Open DOISearch in Google Scholar
Kumar S. AIDS and COVID-19 infections: Impact on vulnerable Indian population. New Microbes New Infect. 2021;42:100903. doi: 10.1016/j.nmni.2021.100903KumarSAIDS and COVID-19 infections: Impact on vulnerable Indian population20214210090310.1016/j.nmni.2021.100903Open DOISearch in Google Scholar
UNICEF. Children, HIV and AIDS. How will progress be impacted by COVID-19? July 2020. Available from: https://data.unicef.org/resources/children-hiv-and-aids-how-will-progress-be-impacted-by-covid-19/July2020Available fromhttps://data.unicef.org/resources/children-hiv-and-aids-how-will-progress-be-impacted-by-covid-19/Search in Google Scholar
UNICEF. Reimagining a resilient HIV response for children, adolescents and pregnant women living with HIV: 2020 World AIDS Day Report. Available from: http://www.childrenandaids.org/sites/default/files/2020-12/2020%20World%20AIDS%20Day%20Report.pdfAvailable fromhttp://www.childrenandaids.org/sites/default/files/2020-12/2020%20World%20AIDS%20Day%20Report.pdfSearch in Google Scholar
Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8(9):e1132-e1141. doi: 10.1016/S2214-109X(20)30288-6HoganABJewellBLSherrard-SmithEVesgaJFWatsonOJWhittakerCet alPotential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study202089e1132e114110.1016/S2214-109X(20)30288-6Open DOISearch in Google Scholar
Grimsrud A, Wilkinson L. Acceleration of differentiated service delivery for HIV treatment in sub-Saharan Africa during COVID-19. J Int AIDS Soc. 2021;24(6):e25704. doi:10.1002/jia2.25704GrimsrudAWilkinsonLAcceleration of differentiated service delivery for HIV treatment in sub-Saharan Africa during COVID-192021246e2570410.1002/jia2.25704Open DOISearch in Google Scholar
UNAIDS. Feature Story: COVID-19’s impact on HIV vertical transmission services reversed. October 2020. Available from: https://www.unaids.org/en/resources/presscentre/featurestories/2020/october/20201027_covid19-impact-hiv-vertical-transmissionOctober2020Available fromhttps://www.unaids.org/en/resources/presscentre/featurestories/2020/october/20201027_covid19-impact-hiv-vertical-transmissionSearch in Google Scholar
The Global Fund: The Impact of COVID-19 on HIV, TB and Malaria Services and Systems for Health: A Snapshot from 502 Health Facilities Across Africa and Asia. April 2021. Available from: https://www.theglobalfund.org/media/10776/covid-19_2020-disruption-impact_report_en.pdfApril2021Available fromhttps://www.theglobalfund.org/media/10776/covid-19_2020-disruption-impact_report_en.pdfSearch in Google Scholar
World Health Organization: Benefits of continuing to provide life-saving HIV services outweigh the risk of COVID-19 transmission by 100 to 1. April 2021. Available from: https://www.who.int/news/item/13-04-2021-benefits-of-continuing-to-provide-life-saving-hiv-services-outweigh-the-risk-of-covid-19-transmission-by-100-to-1April2021Available fromhttps://www.who.int/news/item/13-04-2021-benefits-of-continuing-to-provide-life-saving-hiv-services-outweigh-the-risk-of-covid-19-transmission-by-100-to-1Search in Google Scholar
World Health Organization: HIV/AIDS. Factsheets, July 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aidsFactsheets, July2021Available fromhttps://www.who.int/news-room/fact-sheets/detail/hiv-aidsSearch in Google Scholar
World Health Organization: HIV/AIDS. Factsheets, November 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aidsNovember2020Available fromhttps://www.who.int/news-room/fact-sheets/detail/hiv-aidsSearch in Google Scholar
UNAIDS: Global HIV & AIDS statistics - Fact sheet,2021. Available from: https://www.unaids.org/en/resources/fact-sheet2021Available fromhttps://www.unaids.org/en/resources/fact-sheetSearch in Google Scholar
Majam M, Conserve DF, Zishiri V, Haile ZT, Tembo A, Phiri J, et al. Implementation of different HIV self-testing models with implications for HIV testing services during the COVID-19 pandemic: Study protocol for secondary data analysis of the STAR Initiative in South Africa. BMJ Open. 2021;11(5):e048585. doi: 10.1136/bmjopen-2020-048585MajamMConserveDFZishiriVHaileZTTemboAPhiriJet alImplementation of different HIV self-testing models with implications for HIV testing services during the COVID-19 pandemic: Study protocol for secondary data analysis of the STAR Initiative in South Africa2021115e04858510.1136/bmjopen-2020-048585Open DOISearch in Google Scholar
Jiang H, Zhou Y, Tang W. Maintaining HIV care during the COVID-19 pandemic. Lancet HIV. 2020;7(5):e308-e309. doi: 10.1016/S2352-3018(20)30105-3JiangHZhouYTangWMaintaining HIV care during the COVID-19 pandemic202075e308e30910.1016/S2352-3018(20)30105-3Open DOISearch in Google Scholar
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al; COVE Study Group. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384(5):403-416. doi: 10.1056/NEJMoa2035389BadenLRElSahly HMEssinkBKotloffKFreySNovakRetal; COVE Study GroupEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine2021384540341610.1056/NEJMoa2035389778721933378609Open DOISearch in Google Scholar
Moran A, Mashele N, Mvududu R, Gorbach P, Bekker LG, Coates TJ, Myer L, Joseph Davey D. Maternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation, Retention and Adherence. AIDS Behav. 2021:1–13. doi: 10.1007/s10461-021-03374-xMoranAMasheleNMvududuRGorbachPBekkerLGCoatesTJMyerLJosephDavey DMaternal PrEP Use in HIV-Uninfected Pregnant Women in South Africa: Role of Stigma in PrEP Initiation20211–1310.1007/s10461-021-03374-x829426634287756Open DOISearch in Google Scholar
Rao A. HIV self-test during the time of COVID-19, India. Indian J Med Res. 2020 Jul & Aug;152(1 & 2):164-167. doi: 10.4103/ijmr.IJMR_2521_20RaoAHIV self-test during the time of COVID-19, India2020Jul & Aug;1521 & 216416710.4103/ijmr.IJMR_2521_20785328732896835Open DOISearch in Google Scholar